16 results
PRE 14A
AKRO
Akero Therapeutics Inc
16 Apr 24
Preliminary proxy
4:30pm
Accounting Oversight Board (PCAOB) and issuing a report thereon. The audit committee’s responsibility is to monitor and oversee these processes
DEF 14A
6n38q7hnjhu
27 Apr 20
Definitive proxy
7:30am
10-K
zut32ns
16 Mar 20
Annual report
5:17pm
424B4
dwl3k0i8otvnxkh w1
20 Jun 19
Prospectus supplement with pricing info
5:20pm
S-1/A
k7xlnti5
10 Jun 19
IPO registration (amended)
11:16am
S-1
oxqz fkdi4
24 May 19
IPO registration
4:18pm
DRS/A
qk9o0h
30 Apr 19
Draft registration statement (amended)
12:00am
DRS/A
9udsh9j4p4hzhakbx0
19 Mar 19
Draft registration statement (amended)
12:00am
DRS
43khbg907 dek3m6
17 Jan 19
Draft registration statement
12:00am
- Prev
- 1
- Next